意大利、阿联酋也有中医药中心啦!为中医药领域国际合作树典范

2017-12-22 朱蕗鋆 中国中医

日前,国家中医药管理局副局长王志勇率团访问意大利、阿联酋,出席中国—意大利中医药中心和中国—阿联酋中医药中心成立仪式,并与中国驻外使领馆、当地政府及中医药机构就推动和加强中医药合作进行会谈。

日前,国家中医药管理局副局长王志勇率团访问意大利、阿联酋,出席中国—意大利中医药中心和中国—阿联酋中医药中心成立仪式,并与中国驻外使领馆、当地政府及中医药机构就推动和加强中医药合作进行会谈。

在罗马举行的中国—意大利中医药中心成立仪式上,王志勇指出,意大利的中医药具有良好的发展基础,中医药已成为两国政府合作的重要内容。本次帕拉塞尔苏研究所与罗马萨宾撒大学、世界针灸学会联合会、中国针灸学会等机构合作成立中国—意大利中医药中心,将进一步推动合作各方整合资源,发挥优势,提升合作水平,并为两国中医药领域国际合作树立成功典范。

在迪拜举行的中国—阿联酋中医药中心成立仪式上,王志勇表示,中国—阿联酋中医药中心是中东地区第一所由官方支持合作建立的中医药中心。与迪拜阿瓦尔家族共建中医中心,开展中医医疗和中医药人力资源培训等合作,能将更多中国优质中医药资源引进迪拜,加强本土化中医药人才培养,提升本地中医药服务水平,有利于阿联酋民众享受到更多便捷、优质的中医药服务。

在意期间,代表团分别与中国驻意大利使馆、意大利中华医药学会、意大利北辰之星协会、那不勒斯大学及意大利伊斯基亚市政府就推动和加强中意中医药领域合作进行了会谈。在阿期间,与中国驻迪拜总领馆、迪拜卫生局就加强中医师注册管理、共同支持中国—阿联酋中医药中心建设等内容进行会谈。

国家中医药管理局国际合作司司长王笑频、科技司司长李昱,上海市中医药发展办公室副主任赵致平陪同出访。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1928383, encodeId=57e719283830b, content=<a href='/topic/show?id=ce7c3539270' target=_blank style='color:#2F92EE;'>#医药领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35392, encryptionId=ce7c3539270, topicName=医药领域)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Sun Oct 07 23:10:00 CST 2018, time=2018-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080575, encodeId=8c8120805e57a, content=<a href='/topic/show?id=ea824109e1c' target=_blank style='color:#2F92EE;'>#国际合作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41097, encryptionId=ea824109e1c, topicName=国际合作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed25376, createdName=gdsun, createdTime=Tue Jun 26 04:10:00 CST 2018, time=2018-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796784, encodeId=f77d1e9678417, content=<a href='/topic/show?id=f5a821493f1' target=_blank style='color:#2F92EE;'>#中医药中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21493, encryptionId=f5a821493f1, topicName=中医药中心)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80a244, createdName=d830372, createdTime=Tue Sep 11 21:10:00 CST 2018, time=2018-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1385408, encodeId=6aa41385408b9, content=<a href='/topic/show?id=c31c5322844' target=_blank style='color:#2F92EE;'>#意大利#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53228, encryptionId=c31c5322844, topicName=意大利)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ae503, createdName=pps20019, createdTime=Sun Dec 24 05:10:00 CST 2017, time=2017-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409247, encodeId=4420140924e14, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Dec 24 05:10:00 CST 2017, time=2017-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271537, encodeId=39742e153790, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Fri Dec 22 14:53:00 CST 2017, time=2017-12-22, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1928383, encodeId=57e719283830b, content=<a href='/topic/show?id=ce7c3539270' target=_blank style='color:#2F92EE;'>#医药领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35392, encryptionId=ce7c3539270, topicName=医药领域)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Sun Oct 07 23:10:00 CST 2018, time=2018-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080575, encodeId=8c8120805e57a, content=<a href='/topic/show?id=ea824109e1c' target=_blank style='color:#2F92EE;'>#国际合作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41097, encryptionId=ea824109e1c, topicName=国际合作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed25376, createdName=gdsun, createdTime=Tue Jun 26 04:10:00 CST 2018, time=2018-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796784, encodeId=f77d1e9678417, content=<a href='/topic/show?id=f5a821493f1' target=_blank style='color:#2F92EE;'>#中医药中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21493, encryptionId=f5a821493f1, topicName=中医药中心)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80a244, createdName=d830372, createdTime=Tue Sep 11 21:10:00 CST 2018, time=2018-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1385408, encodeId=6aa41385408b9, content=<a href='/topic/show?id=c31c5322844' target=_blank style='color:#2F92EE;'>#意大利#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53228, encryptionId=c31c5322844, topicName=意大利)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ae503, createdName=pps20019, createdTime=Sun Dec 24 05:10:00 CST 2017, time=2017-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409247, encodeId=4420140924e14, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Dec 24 05:10:00 CST 2017, time=2017-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271537, encodeId=39742e153790, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Fri Dec 22 14:53:00 CST 2017, time=2017-12-22, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1928383, encodeId=57e719283830b, content=<a href='/topic/show?id=ce7c3539270' target=_blank style='color:#2F92EE;'>#医药领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35392, encryptionId=ce7c3539270, topicName=医药领域)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Sun Oct 07 23:10:00 CST 2018, time=2018-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080575, encodeId=8c8120805e57a, content=<a href='/topic/show?id=ea824109e1c' target=_blank style='color:#2F92EE;'>#国际合作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41097, encryptionId=ea824109e1c, topicName=国际合作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed25376, createdName=gdsun, createdTime=Tue Jun 26 04:10:00 CST 2018, time=2018-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796784, encodeId=f77d1e9678417, content=<a href='/topic/show?id=f5a821493f1' target=_blank style='color:#2F92EE;'>#中医药中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21493, encryptionId=f5a821493f1, topicName=中医药中心)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80a244, createdName=d830372, createdTime=Tue Sep 11 21:10:00 CST 2018, time=2018-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1385408, encodeId=6aa41385408b9, content=<a href='/topic/show?id=c31c5322844' target=_blank style='color:#2F92EE;'>#意大利#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53228, encryptionId=c31c5322844, topicName=意大利)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ae503, createdName=pps20019, createdTime=Sun Dec 24 05:10:00 CST 2017, time=2017-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409247, encodeId=4420140924e14, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Dec 24 05:10:00 CST 2017, time=2017-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271537, encodeId=39742e153790, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Fri Dec 22 14:53:00 CST 2017, time=2017-12-22, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1928383, encodeId=57e719283830b, content=<a href='/topic/show?id=ce7c3539270' target=_blank style='color:#2F92EE;'>#医药领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35392, encryptionId=ce7c3539270, topicName=医药领域)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Sun Oct 07 23:10:00 CST 2018, time=2018-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080575, encodeId=8c8120805e57a, content=<a href='/topic/show?id=ea824109e1c' target=_blank style='color:#2F92EE;'>#国际合作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41097, encryptionId=ea824109e1c, topicName=国际合作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed25376, createdName=gdsun, createdTime=Tue Jun 26 04:10:00 CST 2018, time=2018-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796784, encodeId=f77d1e9678417, content=<a href='/topic/show?id=f5a821493f1' target=_blank style='color:#2F92EE;'>#中医药中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21493, encryptionId=f5a821493f1, topicName=中医药中心)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80a244, createdName=d830372, createdTime=Tue Sep 11 21:10:00 CST 2018, time=2018-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1385408, encodeId=6aa41385408b9, content=<a href='/topic/show?id=c31c5322844' target=_blank style='color:#2F92EE;'>#意大利#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53228, encryptionId=c31c5322844, topicName=意大利)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ae503, createdName=pps20019, createdTime=Sun Dec 24 05:10:00 CST 2017, time=2017-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409247, encodeId=4420140924e14, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Dec 24 05:10:00 CST 2017, time=2017-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271537, encodeId=39742e153790, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Fri Dec 22 14:53:00 CST 2017, time=2017-12-22, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1928383, encodeId=57e719283830b, content=<a href='/topic/show?id=ce7c3539270' target=_blank style='color:#2F92EE;'>#医药领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35392, encryptionId=ce7c3539270, topicName=医药领域)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Sun Oct 07 23:10:00 CST 2018, time=2018-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080575, encodeId=8c8120805e57a, content=<a href='/topic/show?id=ea824109e1c' target=_blank style='color:#2F92EE;'>#国际合作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41097, encryptionId=ea824109e1c, topicName=国际合作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed25376, createdName=gdsun, createdTime=Tue Jun 26 04:10:00 CST 2018, time=2018-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796784, encodeId=f77d1e9678417, content=<a href='/topic/show?id=f5a821493f1' target=_blank style='color:#2F92EE;'>#中医药中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21493, encryptionId=f5a821493f1, topicName=中医药中心)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80a244, createdName=d830372, createdTime=Tue Sep 11 21:10:00 CST 2018, time=2018-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1385408, encodeId=6aa41385408b9, content=<a href='/topic/show?id=c31c5322844' target=_blank style='color:#2F92EE;'>#意大利#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53228, encryptionId=c31c5322844, topicName=意大利)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ae503, createdName=pps20019, createdTime=Sun Dec 24 05:10:00 CST 2017, time=2017-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409247, encodeId=4420140924e14, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Dec 24 05:10:00 CST 2017, time=2017-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271537, encodeId=39742e153790, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Fri Dec 22 14:53:00 CST 2017, time=2017-12-22, status=1, ipAttribution=)]
    2017-12-24 cathymary
  6. [GetPortalCommentsPageByObjectIdResponse(id=1928383, encodeId=57e719283830b, content=<a href='/topic/show?id=ce7c3539270' target=_blank style='color:#2F92EE;'>#医药领域#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35392, encryptionId=ce7c3539270, topicName=医药领域)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07f7192, createdName=waiwai3030, createdTime=Sun Oct 07 23:10:00 CST 2018, time=2018-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080575, encodeId=8c8120805e57a, content=<a href='/topic/show?id=ea824109e1c' target=_blank style='color:#2F92EE;'>#国际合作#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41097, encryptionId=ea824109e1c, topicName=国际合作)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed25376, createdName=gdsun, createdTime=Tue Jun 26 04:10:00 CST 2018, time=2018-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1796784, encodeId=f77d1e9678417, content=<a href='/topic/show?id=f5a821493f1' target=_blank style='color:#2F92EE;'>#中医药中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21493, encryptionId=f5a821493f1, topicName=中医药中心)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80a244, createdName=d830372, createdTime=Tue Sep 11 21:10:00 CST 2018, time=2018-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1385408, encodeId=6aa41385408b9, content=<a href='/topic/show?id=c31c5322844' target=_blank style='color:#2F92EE;'>#意大利#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53228, encryptionId=c31c5322844, topicName=意大利)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ae503, createdName=pps20019, createdTime=Sun Dec 24 05:10:00 CST 2017, time=2017-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409247, encodeId=4420140924e14, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Dec 24 05:10:00 CST 2017, time=2017-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=271537, encodeId=39742e153790, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Fri Dec 22 14:53:00 CST 2017, time=2017-12-22, status=1, ipAttribution=)]
    2017-12-22 惠映实验室

    学习了.谢谢.

    0

相关资讯

意大利公众质疑新疫苗政策

种不种,这是个问题!  意大利新疫苗政策引发争议。图片来源:SANOFI PASTEUR 意大利一项提高疫苗接种率以及引入系列新疫苗的政策激发了从医生到公共卫生专家的抗议。这项《2016~2018年国家疫苗计划》(PNPV)将会让意大利很快成为欧洲疫苗接种的领跑者,但是专家却质疑一些疫苗是否必要,一些人则质疑政府热情背后藏着医疗行业的推手。同时,医生担心如果他们不全力

中国姑娘意大利高烧3月不退 回国医治已发展为罕见严重心内膜炎!

昨天,演员李冰冰终于康复出院,微博上贴出在澳大利亚的看病经历,感叹“不用羡慕国外的月亮比国内圆”。 类似的经历也发生在全家移居意大利的温州姑娘小羽身上,如果不是回到国内看病,她还真不敢想象结果会怎么样。 据《今日早报》24日报道,小羽今年24岁,之前在意大利高烧3个月但却一直查不出原因,不得已赶回浙江到浙大一院就诊,被医生确诊为心内膜炎,医生说她的心脏瓣膜都已经被细菌腐蚀了。 高烧三个月,家

意大利生物医学中心计划惹争议

意大利生物医学中心计划惹争议   神经学家Elena Cattaneo向意大利议会表达了对“人类科技城”计划的不满。 图片来源:Tania/A3/Contrasto/eyevine 创建一个耗资15亿欧元(约17亿美元)生物医学和营养研究中心的计划,自意大利总理Matteo Renzi于去年11月宣布以来,便在该国科学家间引发分歧。如今,因为一份由参议员El

Science:意大利政府克扣科学家“工钱”,引发全国性运动

最近,意大利的科学家们对本国政客们的所作所为已经达到忍无可忍了,他们组织了全国范围的对抗国家当前研究体系的运动。科学家们呼吁政府取消多年来的预算限制,并且抵制越来越多的海外科学家来意大利工作。 上周四,几百名研究人员与学生们在罗马Sapienza大学商讨他们的集会方案。 该运动的导火索是由几周前Sapienza的物理学家Giorgio Parisi的一封刊登在《Nature》杂志上的公开信

PLoS One:意大利关于前列腺癌认知、态度和实践筛查研究

最近,有研究人员对前列腺认知、态度和行为以及预防进行了评估。研究人员进行了一项代表性的研究,研究的样本为随机样本,来自于8个公立学校的625名学生的父亲。自行填写的调查问卷包括了以下问题:社会背景、个人和家庭前列腺癌医疗历史、前列腺癌相关知识的认知和前列腺癌特异性抗原(PSA)测试、对前列腺癌风险的看法、对经理PSA测试益处的看法、接受PSA测试的意愿以及对前列腺癌信息和PSA测试的资源和需要。研

富不过三代?NO,1427年的佛罗伦萨有钱人如今依旧富有

意大利佛罗伦萨最富有的家庭,其好光景持续了很长一段时间,确切地说他们的财富传递了六百年。 这是意大利经济学家Guglielmo Barone 和 Sauro Mocetti最近所做研究的结果,他们比较了1427年和2011年这两段不同时期的佛罗伦萨纳税人的情况。他们比较了六百年前和如今有着相同姓氏家庭的财富之后,发现六百年前最富有的佛罗伦萨家庭到如今依旧富有。 Baro